Scottm Robertson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Scottm robertson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Scottm Robertson Today - Breaking & Trending Today

DICE Therapeutics, Inc. (NASDAQ:DICE) Given Average Recommendation of "Hold" by Brokerages

DICE Therapeutics, Inc. (NASDAQ:DICE) Given Average Recommendation of "Hold" by Brokerages
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Scottm Robertson , Wells Fargo Company , Needham Company , Group Plc , Therapeutics Inc , Tower Research Capital , Ameritas Advisory Services , Life Insurance Co , Cantor Fitzgerald , Northpond Ventures Gp Llc , Securities Exchange Commission , Get Free Report , Marketbeat Ratings , Exchange Commission , Advisory Services , Research Capital , Life Insurance , General Group Plc , Get Free ,

Stifel Nicolaus Lowers DICE Therapeutics (NASDAQ:DICE) to Hold

Stifel Nicolaus downgraded shares of DICE Therapeutics (NASDAQ:DICE – Get Rating) from a buy rating to a hold rating in a research report report published on Tuesday morning, The Fly reports. DICE has been the subject of several other research reports. Cowen assumed coverage on shares of DICE Therapeutics in a research report on Wednesday, […] ....

Stifel Nicolaus , Golu Timothy , Scottm Robertson , Therapeutics Inc , Blackrock Inc , Jpmorgan Chase Co , York Mellon Corp , Metlife Investment Management , Canaccord Genuity Group , Wells Fargo Company , Get Rating , New York Mellon Corp , Life Investment Management ,

Brokerages Set DICE Therapeutics, Inc. (NASDAQ:DICE) PT at $62.60

DICE Therapeutics, Inc. (NASDAQ:DICE – Get Rating) has earned an average recommendation of “Moderate Buy” from the thirteen ratings firms that are covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 1-year price objective among analysts […] ....

Scottm Robertson , James Paul Scopa , Life Insurance Co , Group Plc , Canaccord Genuity Group , Needham Company , Dice Therapeutics Inc , Tower Research Capital , Therapeutics Inc , Ameritas Advisory Services , Get Rating , Genuity Group , Director James Paul Scopa , Advisory Services , Research Capital , Life Insurance , General Group Plc ,

DICE Therapeutics, Inc. (NASDAQ:DICE) Short Interest Update

DICE Therapeutics, Inc. (NASDAQ:DICE – Get Rating) saw a large decrease in short interest in the month of May. As of May 15th, there was short interest totalling 8,010,000 shares, a decrease of 9.0% from the April 30th total of 8,800,000 shares. Currently, 20.8% of the company’s shares are sold short. Based on an average […] ....

United States , Richardh Scheller , Scottm Robertson , Barclays Plc , Dice Therapeutics Inc , Vr Adviser , Needham Company , Therapeutics Inc , Td Asset Management Inc , Securities Exchange Commission , Wells Fargo Company , Get Rating , Director Richard , Exchange Commission , Investment Management , State Retirement System , Management Inc , Dice Therapeutics , Nasdaq Dice ,

Analysts Set DICE Therapeutics, Inc. (NASDAQ:DICE) Price Target at $64.63

Shares of DICE Therapeutics, Inc. (NASDAQ:DICE – Get Rating) have been assigned a consensus rating of “Buy” from the eleven analysts that are presently covering the company, MarketBeat reports. Seven analysts have rated the stock with a buy rating. The average 1 year price objective among brokers that have issued ratings on the stock in […] ....

Richardh Scheller , Scottm Robertson , Needham Company , Therapeutics Inc , Securities Exchange Commission , Blackrock Inc , Therapeutics Company Profile , Pricet Rowe Associates Inc , Avoro Capital Advisors , Get Rating , Director Richard , Exchange Commission , Capital Advisors , Trading Down , Dice Therapeutics , Nasdaq Dice ,